Raffaele Califano

@caliraf

Thoracic Oncologist @TheChristieNHS, Honorary Professor @UoM_DCS .
Member @myesmo Educational Publication WG.
Views are my own
No DMs or medical advice given.

Manchester, England Joined March 2011

486 Following 1.1K Followers 1.1K Posts

Latest posts 5

Pinned post

Raffaele Califano @caliraf Jul 31, 2019

I am sorry I cannot respond to specific requests for medical advice or DMs

Raffaele Califano @caliraf Jan 18

ow.ly/6GHk50XVhxw
Deadline for application is 21 jan!
@myESMO @TheChristieNHS @BTOGORG @ALKPositiveinc

Raffaele Califano @caliraf Jan 3

btog.org/amivantamab-wi…

Raffaele Califano @caliraf Sep 7, 2025

Mariposa trial - overall survival

nejm.org/doi/full/10.10…

www.nejm.org Overall Survival with Amivantamab–Lazertinib in EGFR-Mutated Advanced NSCLC | NEJM Previous results from this phase 3 trial showed that progression-free survival among participants with previously untreated EGFR (epidermal growth factor receptor)–mutated advanced non–small-cell l...

Raffaele Califano @caliraf Aug 15, 2025

We have a trial open for patients with advanced EGFR mutant NSCLC (common mut) whose disease has progressed after osimertinib as a later line of therapy. If interested, please contact the-christie.LungResearchTeam@nhs.net
@BTOGORG @EgfrUk @EGFRResisters @RoyCastle